Quince Therapeutics, Inc. (NASDAQ:QNCX – Get Free Report) was the recipient of a significant decrease in short interest in the month of July. Quince Therapeutics Stock PerformanceQuince Therapeutics stock traded up $0.61 during midday trading on Thursday, reaching $22.61. Get Quince Therapeutics alerts:Quince Therapeutics (NASDAQ:QNCX – Get Free Report) last announced its quarterly earnings results on Monday, May 11th. Quince Therapeutics Company Profile(Get Free Report)Quince Therapeutics, Inc, a biopharmaceutical company, focuses on acquiring, developing, and commercializing therapeutics for patients with debilitating and rare diseases. Featured StoriesReceive News & Ratings for Quince Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Quince Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.